Glycobia, a Cornell biotech spin-off that is developing better ways to manufacture protein-based drugs and therapeutics, has become the first tenant/client of our member incubator the McGovern Family Center for Venture Development in the Life Sciences.
In local news coverage, center director Lou Walcer was quoted as noting that Glycobia might otherwise have been bound for Boston, where its board chairman resides, but now plans to double its staff over the next year in the Ithaca area. Other local coverage profiles the incubator itself.
The company’s cofounder is inventor Matthew DeLisa, an associate professor of chemical and biomolecular engineering. Its chief scientific officer is Adam Fisher, a 2008 Cornell Ph.D. For further information, see the university news release posted at the Cornell ChronicleOnline and the attached advisory and background.